| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 12/04/2013 | CN103421746A Monoclonal antibody EEEV-5E4 resisting EEEV E2 protein, B-cell epitope peptide recognized by EEEV-5E4 as well as application of EEEV-5E4 and B-cell epitope peptide |
| 12/04/2013 | CN103421745A Monoclonal antibody EEEV-6E2 resisting EEEV E2 protein, B-cell epitope peptide recognized by EEEV-6E2 as well as application of EEEV-6E2 and B-cell epitope peptid |
| 12/04/2013 | CN103421744A Monoclonal antibody (EEEV-5F4) resisting EEEV I E2 protein, B-cell epitope peptide recognized by EEEV-5F4 as well as application of EEEVI-5F4 and B-cell epitope peptide |
| 12/04/2013 | CN103421743A Recombinant monoclonal antibodies H7 resisting fumonisins B1 |
| 12/04/2013 | CN103421742A Recombinant monoclonal antibodies H2 resisting fumonisins B1 |
| 12/04/2013 | CN103421116A Preparation method, coding sequences and application of anti-hygromycin phosphortransferase monoclonal antibody hybrid tumor |
| 12/04/2013 | CN103421115A CD38 nanometer antibody and application |
| 12/04/2013 | CN103421114A Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| 12/04/2013 | CN103421113A Anti-BLyS antibody |
| 12/04/2013 | CN103421112A Binding molecule capable of resisting enterovirus, and applications thereof |
| 12/04/2013 | CN103421111A Separation, purification and identification of heavychain antibodies in camel milk |
| 12/04/2013 | CN103421107A Applications of novel human latent leukocyte differentiation antigen TMIGD2 discovered by utilization of immunomic technology |
| 12/04/2013 | CN103421072A Dexamethasone semi-antigen, preparation method and applications thereof |
| 12/04/2013 | CN103420879A Dapsone semiantigen, preparation method and applications thereof |
| 12/04/2013 | CN103417967A Application of inhibitor of CXCL-10 in preparation of drug for treatment and/or prevention of lung injury |
| 12/04/2013 | CN102585007B Monoclonal antibody, enzyme-linked immunosorbent assay (ELISA) method and kit for detecting beta-carotene pigments |
| 12/04/2013 | CN102585006B Monoclonal antibody, enzyme-linked immunosorbent assay (ELISA) method and kit for detecting neomycin, amikacin and paromomycin |
| 12/04/2013 | CN102558351B Anti to human alkaline fibroblast growth factor human s c F v antibody and application thereof |
| 12/04/2013 | CN102134275B 表皮生长因子受体变异体 Epidermal growth factor receptor variant |
| 12/04/2013 | CN101287841B Anti-alpha(v)beta(6) antibodies and uses thereof |
| 12/04/2013 | CN101137673B Cripto结合分子 Cripto binding molecules |
| 12/03/2013 | US8598323 Galectin-immunoglobulin chimeric molecules |
| 12/03/2013 | US8598322 Anti CEACAM1 antibodies and methods of using same |
| 12/03/2013 | US8598321 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 12/03/2013 | US8598318 Modified human thymic stromal lymphopoietin |
| 12/03/2013 | US8598314 Peptide-peptidase-inhibitor conjugates and methods of making and using same |
| 12/03/2013 | US8598312 Inhibitors of antigen presentation by MHC class II molecules |
| 12/03/2013 | US8598126 Peptides for inhibiting the HPV-E6 oncoprotein |
| 12/03/2013 | US8598081 Specific delivery of agrochemicals |
| 12/03/2013 | US8597898 Fusion polypeptides capable of activating receptors |
| 12/03/2013 | US8597877 Polymorphic loci that differentiate Escherichia coli O157:H7 from other strains |
| 12/03/2013 | US8597659 Tetrameric cytokines with improved biological activity |
| 12/03/2013 | US8597653 Asymmetrically branched polymer conjugates and microarray assays |
| 12/03/2013 | US8597652 Multispecific anti-HER antibodies |
| 12/03/2013 | US8597651 Monomeric VHH domain derived from anti-VP6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition, prevention and treatment methods for rotavirus infections |
| 12/03/2013 | US8597650 Methods for treating rheumatoid arthritis with anti-bile salt-stimulated lipase (BSSL) antibodies |
| 12/03/2013 | US8597649 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| 12/03/2013 | US8597648 Fully human anti-TNF-alpha monoclonal antibody, preparation method and use thereof |
| 12/03/2013 | US8597647 Humanized anti-IL-20 antibody and uses thereof |
| 12/03/2013 | US8597646 Methods and compositons featuring TGF-beta antagonists for the treatment of marfan syndrome and associated disorders |
| 12/03/2013 | US8597644 Method for treating psoriasis by administering an antibody to interleukin-6 receptor |
| 12/03/2013 | US8597643 Antibodies for binding to non-functional P2X7 receptors in trimeric form |
| 12/03/2013 | US8597636 Method for treating autoimmune diseases and compositions therefor |
| 12/03/2013 | US8597615 Methods of monitoring a human anti-human antibody response and inhibitors thereof |
| 12/03/2013 | CA2555714C Methods for preparing t-cells for cell therapy |
| 12/03/2013 | CA2519227C Nogo receptor binding protein |
| 12/03/2013 | CA2491607C Plant peptide with antimicrobial activity |
| 12/03/2013 | CA2474497C Compositions and methods related to tim-3, a th1-specific cell surface molecule |
| 12/03/2013 | CA2463017C Method for preparation of single chain antibodies |
| 12/03/2013 | CA2397207C Novel stra6 polypeptides |
| 12/03/2013 | CA2240834C Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |
| 12/03/2013 | CA2213610C Ingap protein involved in pancreatic islet neogenesis |
| 11/28/2013 | WO2013177470A1 Selection method for therapeutic agents |
| 11/28/2013 | WO2013177386A1 Biomarkers for predicting response to tweak receptor (tweakr) agonist therapy |
| 11/28/2013 | WO2013177264A1 Anti-ccl2 antibodies for treatment of scleroderma |
| 11/28/2013 | WO2013177197A1 Dendrimer conjugates for coating cells |
| 11/28/2013 | WO2013177157A1 Humanized anti-il-20 antibody and uses thereof |
| 11/28/2013 | WO2013177102A2 Treatment of cancer by manipulating the immune system |
| 11/28/2013 | WO2013177101A2 Bispecific antibodies and methods of using the same |
| 11/28/2013 | WO2013177099A1 Method for treating infectious diseases using emissive energy |
| 11/28/2013 | WO2013177098A1 A method for the treatment of neurologic conditions |
| 11/28/2013 | WO2013177096A1 A method for the treatment of cancer |
| 11/28/2013 | WO2013177062A2 Methods for improving safety of blood-brain barrier transport |
| 11/28/2013 | WO2013176730A1 Recombinant antibody compositions and methods of use thereof |
| 11/28/2013 | WO2013176626A1 Method of identifying foetal erythroblast |
| 11/28/2013 | WO2013176469A1 Antibody able to suppress osteoclast differentiation |
| 11/28/2013 | WO2013176070A1 Cancer detection method |
| 11/28/2013 | WO2013175678A1 Variant protein capable of binding specifically and rapidly to human cardiac troponin i |
| 11/28/2013 | WO2013175427A1 Il-6 binding molecules |
| 11/28/2013 | WO2013175276A1 Il-6 binding molecules |
| 11/28/2013 | WO2013175258A1 Novel melanoma antigen peptide and uses thereof |
| 11/28/2013 | WO2013175256A1 Novel melanoma antigen peptide and uses thereof |
| 11/28/2013 | WO2013175237A1 Composition comprising a cd2 ligation agent and a nkg2d ligation agent |
| 11/28/2013 | WO2013175229A1 Anti -transglutaminase 2 antibodies |
| 11/28/2013 | WO2013174936A1 Aqueous pharmaceutical composition containing a biologic therapeutic agent and guanidine or a guanidine derivative and an injection including the composition |
| 11/28/2013 | WO2013174920A1 Complement component c5a- based vaccine |
| 11/28/2013 | WO2013174873A1 Multispecific antibodies |
| 11/28/2013 | WO2013174537A1 Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages |
| 11/28/2013 | WO2013174510A1 Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| 11/28/2013 | WO2013174509A1 Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| 11/28/2013 | WO2013174404A1 Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| 11/28/2013 | WO2013174403A1 Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| 11/28/2013 | WO2013174264A1 Anti-blys antibody |
| 11/28/2013 | WO2013174003A1 Compositions and methods related to prevention and treatment of rabies infection |
| 11/28/2013 | WO2013173910A1 A novel toxin in type a clostridium perfringens |
| 11/28/2013 | WO2013148256A3 Compositions, kits, and methods for the generation of immunoglobulin sequences |
| 11/28/2013 | WO2013129978A3 Nano-antibody, specifically binding muc1 protein, and method for detecting muc1 protein with the aid of the nano-antibodies |
| 11/28/2013 | WO2013125988A3 Single-domain antibody specifically binding to s100a4/mts1 protein and use of said antibody to detect said protein |
| 11/28/2013 | WO2002077260A8 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 11/28/2013 | US20130317203 Anti-IL-6 Receptor Antibody |
| 11/28/2013 | US20130317202 Test agent for visceral obesity and use thereof |
| 11/28/2013 | US20130317201 Anti-cdh3 antibody having high internalization capacity |
| 11/28/2013 | US20130317200 Methods of Purifying Antibodies |
| 11/28/2013 | US20130317199 Antibodies To Alpha-Synuclein |
| 11/28/2013 | US20130317198 Tandem Purification of Proteins |
| 11/28/2013 | US20130316958 Highly potent peptides to control cancer and neurodegenerative diseases |
| 11/28/2013 | US20130316469 Low Dead Volume Extraction Column Device |
| 11/28/2013 | US20130316450 Compositions and Methods for Diagnosing and Treating Cancer |
| 11/28/2013 | US20130316448 Peptides and related molecules that modulate nerve growth factor activity |
| 11/28/2013 | US20130316403 Vectors and yeast strains for protein production: ca2+ atpase overexpression |